0000899243-23-010596.txt : 20230404 0000899243-23-010596.hdr.sgml : 20230404 20230404211959 ACCESSION NUMBER: 0000899243-23-010596 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230401 FILED AS OF DATE: 20230404 DATE AS OF CHANGE: 20230404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LIU JEAN I CENTRAL INDEX KEY: 0001241357 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 23800975 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-01 0 0001060736 Seagen Inc. SGEN 0001241357 LIU JEAN I 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 Chief Legal Officer 0 Common Stock 2023-04-01 4 A 0 1389 0.00 A 86502 D These restricted stock units will be settled in common stock upon vesting. The restricted stock units shall vest 37.5% on the 18 month anniversary of the grant date, 31.25% on the 24 month anniversary of the grant date, and 31.25% on the 30 month anniversary of the grant date. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. By: /s/ Jennifer Prosba For: Jean I. Liu 2023-04-04